Psoriasis
What are the most common adverse reactions seen with ixekizumab?
Featuring Raj Chovatiya, MD, PhD, MSCI
Psoriasis
What factors should be considered when determining optimal treatment duration for ixekizumab in patients with psoriasis?
Featuring Raj Chovatiya, MD, PhD, MSCI
Psoriasis
When do you consider a biologic as a first-line treatment for psoriasis?
Featuring Raj Chovatiya, MD, PhD, MSCI
Psoriasis
What are some common reasons for undertreatment of patients with psoriasis and how can dermatologists address this?
Featuring Raj Chovatiya, MD, PhD, MSCI
Psoriasis
What is your approach when counseling a patient who has experienced multiple treatment failures?
Featuring Raj Chovatiya, MD, PhD, MSCI
Psoriasis
What role does patient education play in improving adherence to psoriasis treatment regimens?
Featuring Raj Chovatiya, MD, PhD, MSCI
Psoriasis
How do newer biologic agents like IL-17 inhibitors compare to traditional biologics in psoriasis treatment?
Featuring Raj Chovatiya, MD, PhD, MSCI
Vitiligo
Can ruxolitinib be used as a first-line treatment for vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
What is your recommended approach for managing patients who do not respond to ruxolitinib therapy for vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation
Featuring Benjamin Lockshin, MD
Vitiligo
How should you counsel patients about the risk of NMSC while using ruxolitinib for vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
Are there any contraindications or precautions dermatologists should consider before beginning a patient on ruxolitinib for vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
Is there any recommended monitoring for patients on ruxolitinib for vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
How soon should treatment be initiated after diagnosing vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
What factors should be considered when selecting treatment for pediatric patients with vitiligo?
Featuring Benjamin Lockshin, MD
Vitiligo
How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation?
Featuring Cheri Frey, MD
Vitiligo
How does ruxolitinib compare to other treatment options for vitiligo?
Featuring Cheri Frey, MD
Vitiligo
Is there any risk of rebound or worsening of vitiligo symptoms after discontinuing ruxolitinib?
Featuring Cheri Frey, MD
24 of 554